| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 1999;68:799-803
© 1999 The Society of Thoracic Surgeons
a Department of Thoracic and Cardiovascular Surgery, College of Medicine, Seoul National University, Seoul, South Korea
b Department of Internal Medicine, College of Medicine, Seoul National University, Seoul, South Korea
Address reprint requests to Dr Kim, Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, 28 Yeun-Kun Dong, Chong-Ro Ku, Seoul 110-744, Korea
Presented at the Thirty-fifth Annual Meeting of The Society of Thoracic Surgeons, San Antonio, TX, Jan 25–27, 1999.
Background. The surgical results of the Cox-Maze III procedure (CM-III) for atrial fibrillation (AF) associated with rheumatic mitral valve (MV) disease are not as good as the results from surgery for AF alone.
Methods. To assess the efficacy and safety of the CM-III in AF associated with rheumatic MV disease, we retrospectively analyzed 75 patients who underwent the CM-III combined with a rheumatic MV procedure between April 1994 and December 1997. Fourteen cases were reoperations because of prosthetic valve failure.
Results. Mean aortic cross-clamp (ACC) times and cardiopulmonary bypass (CPB) times were 151 ± 43 and 251 ± 73 min, respectively. Concomitant procedures were mitral valve replacement (MVR) in 25 patients, MVR and aortic valve replacement (AVR) in 14 patients, MV repair in 10 patients, MVR and tricuspid annuloplasty (TAP) in 6 patients, MVR and AV repair in 3 patients, MVR and coronary artery bypass grafting (CABG) in 2 patients, MVR and AVR and CABG in 1 patient, redo-MVR in 8 patients, redo-MVR and TAP in 4 patients, and redo-MVR and redo-AVR in 2 patients. There were two in-hospital mortalities (2 of 75, 2.7%). Seventy-three survivors were followed for a mean duration of 30 ± 13 months (12–56 months). Normal sinus rhythm was restored in 90.4% (66 of 73). Three patients remained in AF and 2 patients were in junctional rhythm. Permanent pacemakers were implanted in 2 patients due to sick sinus syndrome. Right atrial (RA) contractility was demonstrable in 100% (66 of 66) and left atrial (LA) contractility in 62.1% (41 of 66) of the patients in the latest follow-up echocardiography. RA and LA contractilities were restored a mean 69 ± 93 and 126 ± 136 days after the operation, respectively. LA contractility was restored significantly later at a lower rate than RA contractility in rheumatic MV disease. There were no differences in ACC time, CPB time, incidence of postoperative bleeding complications, and sinus conversion rates between nonredo and redo cases in spite of the significantly longer duration of preoperative AF in redo cases (p < 0.05).
Conclusions. The CM-III for AF associated with rheumatic MV disease demonstrated a high sinus conversion rate with acceptable operative risk even in cases of reoperation.
This article has been cited by other articles:
|
|
 |
|
  S. Lonnerholm, P. Blomstrom, L. Nilsson, and C. Blomstrom-Lundqvist A high quality of life is maintained late after Maze III surgery for atrial fibrillation Eur. J. Cardiothorac. Surg., September 1, 2009; 36(3): 558 - 562. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Lonnerholm, P. Blomstrom, L. Nilsson, and C. Blomstrom-Lundqvist Long-Term Effects of the Maze Procedure on Atrial Size and Mechanical Function Ann. Thorac. Surg., March 1, 2008; 85(3): 916 - 920. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.-B. Kim Reply to Villa et al. Eur. J. Cardiothorac. Surg., August 1, 2007; 32(2): 399 - 399. [Full Text] [PDF]
|
|
|
|
|
|
K. C. Kim, K. R. Cho, Y.-J. Kim, D.-W. Sohn, and K.-B. Kim Long-term results of the Cox-Maze III procedure for persistent atrial fibrillation associated with rheumatic mitral valve disease: 10-year experience Eur. J. Cardiothorac. Surg., February 1, 2007; 31(2): 261 - 266. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. K.E.W. Ballaux, G. S.C. Geuzebroek, N. M. van Hemel, J. C. Kelder, K. M.E. Dossche, J. M.P.G. Ernst, L. V.A. Boersma, E. F.D. Wever, A. B. de la Riviere, and J. J.A.M.T. Defauw Freedom from atrial arrhythmias after classic maze III surgery: A 10-year experience J. Thorac. Cardiovasc. Surg., December 1, 2006; 132(6): 1433 - 1440. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D. Barnett and N. Ad Surgical ablation as treatment for the elimination of atrial fibrillation: A meta-analysis J. Thorac. Cardiovasc. Surg., May 1, 2006; 131(5): 1029 - 1035. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-K. Kim, Y.-J. Kim, K.-I. Kim, S.-H. Jo, K.-B. Kim, H. Ahn, D.-W. Sohn, B.-H. Oh, M.-M. Lee, Y.-B. Park, et al. Impact of the Maze Operation Combined With Left-Sided Valve Surgery on the Change in Tricuspid Regurgitation Over Time Circulation, August 30, 2005; 112(9_suppl): I-14 - I-19. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Vora, D. Karnad, V. Goyal, A. Naik, A. Gupta, Y. Lokhandwala, H. Kulkarni, and B. N. Singh Control of Heart Rate Versus Rhythm in Rheumatic Atrial Fibrillation: A Randomized Study Journal of Cardiovascular Pharmacology and Therapeutics, April 1, 2004; 9(2): 65 - 73. [Abstract] [PDF]
|
|
|
|
|
|
H. T. Sie, W. P. Beukema, A. Elvan, and A. R. Ramdat Misier Long-term results of irrigated radiofrequency modified maze procedure in 200 patients with concomitant cardiac surgery: six years experience Ann. Thorac. Surg., February 1, 2004; 77(2): 512 - 517. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. R. Jessurun, J. M. T. de Bakker, N. M. van Hemel, T. Opthof, A. C. Linnenbank, P. F. H. M. van Dessel, J. J. A. M. T. Defauw, and A. B. de la Riviere Right atrial modification of maze surgery does not affect refractoriness and conduction patterns of human lone atrial fibrillation Europace, January 1, 2003; 5(1): 39 - 46. [Abstract] [PDF]
|
|
|
|
|
|
S. Benussi, S. Nascimbene, E. Agricola, G. Calori, S. Calvi, A. Caldarola, M. Oppizzi, V. Casati, C. Pappone, and O. Alfieri Surgical ablation of atrial fibrillation using the epicardial radiofrequency approach: mid-term results and risk analysis Ann. Thorac. Surg., October 1, 2002; 74(4): 1050 - 1057. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Nakajima, J. Kobayashi, K. Bando, K. Niwaya, O. Tagusari, Y. Sasako, T. Nakatani, and S. Kitamura The Effect of Cryo-Maze Procedure on Early and Intermediate Term Outcome in Mitral Valve Disease: Case Matched Study Circulation, September 24, 2002; 106(12_suppl_1): I-46 - I-50. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Guang, C. Zhen-jie, L. Wei Yong, L. Tong, and L. Ying Evaluation of clinical treatment of atrial fibrillation associated with rheumatic mitral valve disease by radiofrequency ablation Eur. J. Cardiothorac. Surg., February 1, 2002; 21(2): 249 - 254. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Lonnerholm, P. Blomstrom, L. Nilsson, and C. Blomstrom-Lundqvist Atrial size and transport function after the Maze III procedure for paroxysmal atrial fibrillation Ann. Thorac. Surg., January 1, 2002; 73(1): 107 - 111. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Kabbani, H. Jamil, A. Hammoud, F. Nabhani, R. Hariri, N. Sabbagh, and D. N. Ross Use of the pulmonary autograft for mitral replacement: short- and medium-term experience Eur. J. Cardiothorac. Surg., August 1, 2001; 20(2): 257 - 261. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. T. Sie, W. P. Beukema, A. R. R. Misier, A. Elvan, J. J. Ennema, M. M.P. Haalebos, and H. J.J. Wellens Radiofrequency modified maze in patients with atrial fibrillation undergoing concomitant cardiac surgery J. Thorac. Cardiovasc. Surg., August 1, 2001; 122(2): 249 - 256. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. T. Sie, W. P. Beukema, A. R. Ramdat Misier, A. Elvan, J. J. Ennema, and H. J.J. Wellens The radiofrequency modified maze procedure. A less invasive surgical approach to atrial fibrillation during open-heart surgery Eur. J. Cardiothorac. Surg., April 1, 2001; 19(4): 443 - 447. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.-B. Kim, J.-H. Huh, C. H. Kang, H. Ahn, and D.-W. Sohn Modifications of the Cox-Maze III procedure Ann. Thorac. Surg., March 1, 2001; 71(3): 816 - 822. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Kabbani Is an optimal mitral substitute within reach? Ann. Thorac. Surg., June 1, 2000; 69(6): 1651 - 1652. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
